ArticleOncoTargets and therapy2021

Rapid Response to Pembrolizumab in a Chemo-Refractory Testicular Germ Cell Cancer with Microsatellite Instability-High.

Koji Kawai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.